Why Elliott Just Bet Billions on Synopsys – And Wants More Money From Its Must-Have Software
Elliott Investment Management acquires multibillion-dollar stake in Synopsys to boost margins and monetization in the exploding AI chip sector.
NOTRELOAD AI
Maven Goes Official: Palantir’s AI Now Permanent Part of U.S. Military
Deputy SecDef Steve Feinberg orders Palantir's Maven AI system as a program of record, securing long-term funding and integration across U.S. forces by September 2026.
Wolfe Research Turns Bullish on Celldex, Upgrading to Outperform and Citing Stronger 2026 Catalysts
Wolfe Research upgrades Celldex Therapeutics to Outperform from Peer Perform, citing stronger 2026 catalysts and depressed valuation for rebound potential.
Pfizer and Valneva Lyme Vaccine Shows Over 70% Efficacy in Phase 3 Trial — But Misses Main Goal
Pfizer and Valneva reported their Lyme disease vaccine demonstrated 73.2% efficacy in the Phase 3 VALOR trial. While it missed the primary statistical target due to fewer cases, strong results support upcoming regulatory submissions.
iPhone’s Big Comeback: Morgan Stanley Sees Apple Gaining Market Share in 2026
Morgan Stanley’s survey shows iPhone upgrades at record highs, switching to Apple at 5-year peak. Apple set to be only major brand gaining share in 2026.
USA Rare Earth Teams Up with Arnold Magnetic to Boost American-Made Magnets for Missiles, Jets & Semiconductors
USA Rare Earth and Arnold Magnetic Technologies partner to expand U.S.-made rare earth magnets for aerospace, defense, semiconductors, and advanced tech.